Lindahl advised Nanologica on the offering. Nanologica finalized a rights issuance, which was resolved by the board of directors on 29 August 2024 and approved by...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here